Search research articles
Contact Us
Filters
Showing results (101-110 of 140) with videos related to
Page
of 14
Sort By:
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer
Nilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
Cancer Research Communications
|
July 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
Siddharth Mehra, Vanessa T Garrido, Austin R Dosch, et al.
Journal of Surgical Oncology
|
August 11, 2021
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis
Joshua P Kronenfeld, Amber L Collier, Michael K Turgeon, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Oncoimmunology
|
September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER<sup>pos</sup>/HER2<sup>pos</sup> early breast cancer
Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Annals of Surgical Oncology
|
May 5, 2022
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium
Kristin N Kelly, Francisco I Macedo, Max Seaton, et al.
Cancer Research
|
January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P Singh, Austin R Dosch, Siddharth Mehra, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 13, 2022
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling
Siddharth Mehra, Supriya Srinivasan, Samara Singh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 4, 2024
Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancer
Gerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 140) with videos related to
Sort By:
Page
of 14
Biorxiv : the Preprint Server for Biology
|
June 10, 2024
Cell-specific nanoengineering strategy disrupts tolerogenic signaling from myeloid-derived suppressor cells to invigorate antitumor immunity in pancreatic cancer
Nilesh U Deshpande, Anna Bianchi, Haleh Amirian, et al.
Cancer Research Communications
|
July 14, 2023
Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
Siddharth Mehra, Vanessa T Garrido, Austin R Dosch, et al.
Journal of Surgical Oncology
|
August 11, 2021
Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis
Joshua P Kronenfeld, Amber L Collier, Michael K Turgeon, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Oncoimmunology
|
September 22, 2017
Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER<sup>pos</sup>/HER2<sup>pos</sup> early breast cancer
Lea Lowenfeld, Salman Zaheer, Crystal Oechsle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 17, 2025
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Annals of Surgical Oncology
|
May 5, 2022
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium
Kristin N Kelly, Francisco I Macedo, Max Seaton, et al.
Cancer Research
|
January 29, 2024
Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer
Samara P Singh, Austin R Dosch, Siddharth Mehra, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 13, 2022
Urolithin A attenuates severity of chronic pancreatitis associated with continued alcohol intake by inhibiting PI3K/AKT/mTOR signaling
Siddharth Mehra, Supriya Srinivasan, Samara Singh, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
March 4, 2024
Patient metabolic profile defined by liver and muscle <sup>18</sup>F-FDG PET avidity is independently associated with overall survival in gastric cancer
Gerardo A Vitiello, Vetri Sudar Jayaprakasam, Laura H Tang, et al.
Page
of 14